Penumbra Total Assets 2014-2023 | PEN
- Penumbra total assets for the quarter ending December 31, 2023 were $1.556B, a 13.53% increase year-over-year.
- Penumbra total assets for 2023 were $1.556B, a 13.53% increase from 2022.
- Penumbra total assets for 2022 were $1.371B, a 10.18% increase from 2021.
- Penumbra total assets for 2021 were $1.244B, a 51.19% increase from 2020.
Penumbra Annual Total Assets (Millions of US $) |
|
---|---|
2023 | $1,556 |
2022 | $1,371 |
2021 | $1,244 |
2020 | $823 |
2019 | $666 |
2018 | $515 |
2017 | $477 |
2016 | $308 |
2015 | $264 |
2014 | $121 |
2013 | $71 |
Penumbra Quarterly Total Assets (Millions of US $) |
|
---|---|
2023-12-31 | $1,556 |
2023-09-30 | $1,468 |
2023-06-30 | $1,433 |
2023-03-31 | $1,395 |
2022-12-31 | $1,371 |
2022-09-30 | $1,322 |
2022-06-30 | $1,328 |
2022-03-31 | $1,302 |
2021-12-31 | $1,244 |
2021-09-30 | $973 |
2021-06-30 | $910 |
2021-03-31 | $841 |
2020-12-31 | $823 |
2020-09-30 | $810 |
2020-06-30 | $780 |
2020-03-31 | $664 |
2019-12-31 | $666 |
2019-09-30 | $614 |
2019-06-30 | $585 |
2019-03-31 | $569 |
2018-12-31 | $515 |
2018-09-30 | $501 |
2018-06-30 | $499 |
2018-03-31 | $490 |
2017-12-31 | $477 |
2017-09-30 | $459 |
2017-06-30 | $417 |
2017-03-31 | $418 |
2016-12-31 | $308 |
2016-09-30 | $297 |
2016-06-30 | $284 |
2016-03-31 | $275 |
2015-12-31 | $264 |
2015-09-30 | $259 |
2015-06-30 | $0 |
2015-03-31 | $0 |
2014-12-31 | $0 |
2014-09-30 | $0 |
2013-12-31 | $71 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $8.762B | $1.059B |
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $220.921B | 26.90 |
Intuitive Surgical (ISRG) | United States | $141.815B | 88.52 |
Edwards Lifesciences (EW) | United States | $57.273B | 37.91 |
DexCom (DXCM) | United States | $53.772B | 92.37 |
IQVIA Holdings (IQV) | United States | $45.841B | 27.19 |
IDEXX Laboratories (IDXX) | United States | $44.833B | 53.58 |
Alcon (ALC) | Switzerland | $41.065B | 30.28 |
STERIS (STE) | Ireland | $22.285B | 26.38 |
Waters (WAT) | United States | $20.436B | 29.38 |
Hologic (HOLX) | United States | $18.156B | 20.04 |
SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.065B | 83.36 |
Sysmex ADR (SSMXY) | Japan | $11.407B | 35.78 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.361B | 14.03 |
Teleflex (TFX) | United States | $10.535B | 16.56 |
Masimo (MASI) | United States | $7.645B | 42.87 |
Globus Medical (GMED) | United States | $7.183B | 22.77 |
Glaukos (GKOS) | United States | $4.585B | 0.00 |
Integer Holdings (ITGR) | United States | $3.844B | 24.64 |
LivaNova (LIVN) | United Kingdom | $3.015B | 19.88 |
Elekta AB (EKTAY) | Sweden | $2.904B | 19.92 |
Inari Medical (NARI) | United States | $2.747B | 474.00 |
Integra LifeSciences Holdings (IART) | United States | $2.738B | 11.23 |
PROCEPT BioRobotics (PRCT) | United States | $2.489B | 0.00 |
TransMedics (TMDX) | United States | $2.424B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.388B | 20.19 |
Tandem Diabetes Care (TNDM) | United States | $2.317B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.904B | 0.00 |
RxSight (RXST) | United States | $1.874B | 0.00 |
Veracyte (VCYT) | United States | $1.586B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.997B | 0.00 |
Paragon 28 (FNA) | United States | $0.987B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.01 |
Artivion (AORT) | United States | $0.891B | 103.00 |
Treace Medical Concepts (TMCI) | United States | $0.763B | 0.00 |
OPKO Health (OPK) | United States | $0.746B | 0.00 |
Silk Road Medical (SILK) | United States | $0.733B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.650B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.579B | 19.64 |
IRadimed (IRMD) | United States | $0.549B | 31.89 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
Nevro (NVRO) | United States | $0.525B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.463B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.377B | 12.69 |
CVRx (CVRX) | United States | $0.376B | 0.00 |
NeuroPace (NPCE) | United States | $0.358B | 0.00 |
AxoGen (AXGN) | United States | $0.336B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
Accuray (ARAY) | United States | $0.241B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.229B | 0.00 |
908 Devices (MASS) | United States | $0.229B | 0.00 |
AngioDynamics (ANGO) | United States | $0.227B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
Semler Scientific (SMLR) | United States | $0.201B | 10.81 |
Inogen (INGN) | United States | $0.186B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.181B | 0.00 |
Neuronetics (STIM) | United States | $0.143B | 0.00 |
Delcath Systems (DCTH) | United States | $0.125B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.118B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.076B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.073B | 0.00 |
Hyperfine (HYPR) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.064B | 130.67 |
Vasomedical (VASO) | United States | $0.057B | 4.36 |
InspireMD (NSPR) | Israel | $0.054B | 0.00 |
Autonomix Medical (AMIX) | $0.052B | 0.00 | |
Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
LENSAR (LNSR) | United States | $0.043B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.025B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.022B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.018B | 0.00 |
Check-Cap (CHEK) | Israel | $0.016B | 0.00 |
NexGel (NXGL) | United States | $0.015B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.007B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |